XML 26 R13.htm IDEA: XBRL DOCUMENT v3.4.0.3
Note 4 - Debt and Equity Securities
3 Months Ended
Mar. 31, 2016
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
4.
Debt and Equity Securities
 
The Company’s investments in equity securities that have readily determinable fair values and all investments in debt securities are classified in one of the following three categories and accounted for accordingly: (1) trading securities, (2) securities available for sale and (3) securities held-to-maturity.
 
The Company did not hold any trading securities at March 31, 2016 and December 31, 2015. Securities available for sale are recorded at fair value. Securities held-to-maturity are recorded at amortized cost.
 
The following table summarizes the Company’s portfolio of securities held-to-maturity at March 31, 2016:
 
    Amortized
Cost
  Fair Value   Gross
Unrealized
Gains
  Gross
Unrealized
Losses
    (In thousands)
Securites held-to-maturity:                                
Municipals   $ 7,885     $ 7,885     $ -     $ -  
                                 
Total   $ 7,885     $ 7,885     $ -     $ -  
 
The following table summarizes the Company’s portfolio of securities held-to-maturity at December 31, 2015:
 
    Amortized
Cost
  Fair Value   Gross
Unrealized
Gains
  Gross
Unrealized
Losses
    (In thousands)
Securites held-to-maturity:                                
Municipals   $ 6,180     $ 6,180     $ -     $ -  
                                 
Total   $ 6,180     $ 6,180     $ -     $ -  
 
The following table summarizes the Company’s portfolio of securities available for sale at March 31, 2016:
 
    Amortized
Cost
  Fair Value   Gross
Unrealized
Gains
  Gross
Unrealized
Losses
    (In thousands)
Corporate   $ 115,993     $ 111,399     $ 592     $ 5,186  
Municipals     127,023       131,869       4,846       -  
Mutual funds     21,507       21,507       -       -  
Collateralized loan obligations     101,613       100,926       33       720  
Other     7,154       7,150       -       4  
Total other securities     373,290       372,851       5,471       5,910  
REMIC and CMO     462,677       470,194       8,107       590  
GNMA     10,832       11,122       325       35  
FNMA     167,229       170,511       3,543       261  
FHLMC     16,351       16,585       234       -  
Total mortgage-backed securities     657,089       668,412       12,209       886  
Total securities available for sale   $ 1,030,379     $ 1,041,263     $ 17,680     $ 6,796  
 
Mortgage-backed securities shown in the table above includes one private issue collateralized mortgage obligation (“CMO”) that is collateralized by commercial real estate mortgages with amortized cost and market value of $7.6 million at March 31, 2016.
 
 
The following table summarizes the Company’s portfolio of securities available for sale at December 31, 2015:
 
    Amortized
Cost
  Fair Value   Gross
Unrealized
Gains
  Gross
Unrealized
Losses
    (In thousands)
Corporate   $ 115,976     $ 111,674     $ 134     $ 4,436  
Municipals     127,696       131,583       3,887       -  
Mutual funds     21,290       21,290       -       -  
Collateralized loan obligations     53,225       52,898       -       327  
Other     7,214       7,212       -       2  
Total other securities     325,401       324,657       4,021       4,765  
REMIC and CMO     469,987       469,936       3,096       3,147  
GNMA     11,635       11,798       302       139  
FNMA     170,327       170,057       1,492       1,762  
FHLMC     16,961       16,949       87       99  
Total mortgage-backed securities     668,910       668,740       4,977       5,147  
Total securities available for sale   $ 994,311     $ 993,397     $ 8,998     $ 9,912  
 
Mortgage-backed securities shown in the table above includes one private issue CMO that is collateralized by commercial real estate mortgages with an amortized cost and market value of $7.7 million at December 31, 2015.
 
The following table details the amortized cost and fair value of the Company’s securities classified as held-to-maturity at March 31, 2016, by contractual maturity. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
 
    Amortized
Cost
  Fair Value
    (In thousands)
         
Due in one year or less   $ 6,845     $ 6,845  
Due after one year through five years     1,040       1,040  
                 
Total securities held-to-maturity   $ 7,885     $ 7,885  
 
The amortized cost and fair value of the Company’s securities, classified as available for sale at March 31, 2016, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
 
    Amortized
Cost
  Fair Value
    (In thousands)
         
Due in one year or less   $ 5,993     $ 6,003  
Due after one year through five years     1,825       1,855  
Due after five years through ten years     74,821       74,261  
Due after ten years     269,144       269,225  
                 
Total other securities     351,783       351,344  
Mutual funds     21,507       21,507  
Mortgage-backed securities     657,089       668,412  
                 
Total securities available for sale   $ 1,030,379     $ 1,041,263  
 
 
The following table shows the Company’s available for sale securities with gross unrealized losses and their fair value, aggregated by category and length of time that individual securities have been in a continuous unrealized loss position, at March 31, 2016:
 
        Total   Less than 12 months   12 months or more
    Count   Fair Value   Unrealized
Losses
  Fair Value   Unrealized
Losses
  Fair Value   Unrealized
Losses
        (Dollars in thousands)
Corporate     11     $ 74,813     $ 5,186     $ 56,128     $ 3,871     $ 18,685     $ 1,315  
Collateralized loan obligations     9       72,328       720       72,328       720       -       -  
Other     1       296       4       -       -       296       4  
Total other securities     21       147,437       5,910       128,456       4,591       18,981       1,319  
                                                         
REMIC and CMO     10       49,379       590       13,733       60       35,646       530  
GNMA     1       6,786       35       -       -       6,786       35  
FNMA     4       26,415       261       -       -       26,415       261  
Total mortgage-backed securities     15       82,580       886       13,733       60       68,847       826  
Total securities available for sale     36     $ 230,017     $ 6,796     $ 142,189     $ 4,651     $ 87,828     $ 2,145  
 
The following table shows the Company’s available for sale securities with gross unrealized losses and their fair value, aggregated by category and length of time that individual securities have been in a continuous unrealized loss position, at December 31, 2015:
 
        Total   Less than 12 months   12 months or more
    Count   Fair Value   Unrealized
Losses
  Fair Value   Unrealized
Losses
  Fair Value   Unrealized
Losses
        (Dollars in thousands)
Corporate     12     $ 85,563     $ 4,436     $ 76,218     $ 3,782     $ 9,345     $ 654  
Collateralized loan obligations     7       52,898       327       52,898       327       -       -  
Other     1       298       2       -       -       298       2  
Total other securities     20       138,759       4,765       129,116       4,109       9,643       656  
                                                         
REMIC and CMO     33       238,132       3,147       182,010       1,642       56,122       1,505  
GNMA     1       6,977       139       6,977       139       -       -  
FNMA     20       102,225       1,762       75,769       1,043       26,456       719  
FHLMC     3       14,715       99       14,715       99       -       -  
Total mortgage-backed securities     57       362,049       5,147       279,471       2,923       82,578       2,224  
Total securities available for sale     77     $ 500,808     $ 9,912     $ 408,587     $ 7,032     $ 92,221     $ 2,880  
 
OTTI losses on impaired securities must be fully recognized in earnings if an investor has the intent to sell the debt security or if it is more likely than not that the investor will be required to sell the debt security before recovery of its amortized cost. However, even if an investor does not expect to sell a debt security, the investor must evaluate the expected cash flows to be received and determine if a credit loss has occurred. In the event that a credit loss has occurred, only the amount of impairment associated with the credit loss is recognized in earnings in the Consolidated Statements of Income. Amounts relating to factors other than credit losses are recorded in accumulated other comprehensive income (“AOCI”) within Stockholders’ Equity.
 
The Company reviewed each investment that had an unrealized loss at March 31, 2016 and December 31, 2015. An unrealized loss exists when the current fair value of an investment is less than its amortized cost basis. Unrealized losses on available for sale securities, that are deemed to be temporary, are recorded in AOCI, net of tax.
 
The unrealized losses in total securities available for sale at March 31, 2016 and December 31, 2015 were caused by movements in interest rates. It is not anticipated that these securities would be settled at a price that is less than the amortized cost of the Company’s investment. Each of these securities is performing according to its terms and, in the opinion of management, will continue to perform according to its terms. The Company does not have the intent to sell these securities and it is more likely than not the Company will not be required to sell the securities before recovery of the securities’ amortized cost basis. This conclusion is based upon considering the Company’s cash and working capital requirements and contractual and regulatory obligations, none of which the Company believes would cause the sale of the securities. Therefore, the Company did not consider these investments to be other-than-temporarily impaired at March 31, 2016 and December 31, 2015.
 
We did not sell any securities during the three months ended March 31, 2016 and 2015.